SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-061775
Filing Date
2024-07-16
Accepted
2024-07-16 16:05:13
Documents
15
Period of Report
2024-07-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209365-8k_avalon.htm   iXBRL 8-K 36928
2 LETTER FROM MARCUM LLP, DATED JULY 16, 2024, ADDRESSED TO THE SECURITIES AND EXC ea0209365ex16-1_avalon.htm EX-16.1 1970
6 GRAPHIC image_001.jpg GRAPHIC 8745
  Complete submission text file 0001213900-24-061775.txt   226764

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE albt-20240710.xsd EX-101.SCH 3039
4 XBRL LABEL FILE albt-20240710_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE albt-20240710_pre.xml EX-101.PRE 22375
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0209365-8k_avalon_htm.xml XML 3684
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 241119706
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)